title: Symmetrical lupoid onychodystrophy in dogs: a retrospective analysis of 18 cases (1989-1993).
abstract: A unique, symmetrical onychodystrophy is described in 18 dogs. A rather sudden onset of onychomadesis is followed by chronic onychodystrophy affecting all claws. Pain and lameness are recognized in half of the patients, but the dogs are healthy otherwise. Histopathologically, this disorder is characterized by hydropic and lichenoid interface dermatitis. Nine dogs were treated with a commercial, fatty-acid supplement and had good-to-excellent responses. Due to the clinicopathological characteristics of this disorder, the authors propose the name "symmetrical lupoid onychodystrophy."
authors.affiliation: Department of Clinical Sciences, College of Veterinary Medicine, Cornell University, Ithaca, New York 14853, USA.
authors.forename: D W
authors.initials: DW
authors.lastname: Scott
authors.forename: S
authors.initials: S
authors.lastname: Rousselle
authors.forename: W H
authors.initials: WH
authors.lastname: Miller
mesh_terms: D000818:Animals; D001706:Biopsy / Q000662:veterinary; D003872:Dermatitis / Q000175:diagnosis / Q000188:drug therapy / Q000662:veterinary; D004283:Dog Diseases / Q000175:diagnosis* / Q000188:drug therapy; D004285:Dogs; D015525:Fatty Acids, Omega-3 / Q000627:therapeutic use; D043371:Fatty Acids, Omega-6; D005231:Fatty Acids, Unsaturated / Q000627:therapeutic use; D005260:Female; D005533:Foot Dermatoses / Q000175:diagnosis / Q000188:drug therapy / Q000662:veterinary; D006724:Hoof and Claw / Q000187:drug effects / Q000473:pathology*; D007794:Lameness, Animal / Q000175:diagnosis / Q000188:drug therapy; D008297:Male; D010146:Pain / Q000175:diagnosis / Q000188:drug therapy / Q000662:veterinary; D011241:Prednisone / Q000627:therapeutic use; D012189:Retrospective Studies; D014810:Vitamin E / Q000627:therapeutic use
chemical_list: D015525:Fatty Acids, Omega-3; D043371:Fatty Acids, Omega-6; D005231:Fatty Acids, Unsaturated; D014810:Vitamin E; D011241:Prednisone